CEP
RGNX icon

Chicago Equity Partners’s Regenxbio RGNX Stock Holding History

Chicago Equity Partners’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,605
Closed -$200K – 944
2019
Q3 		$200K Hold
5,605
– – 0.01% 837
2019
Q2 		$288K Sell
5,605
-6,310
-53% -$315K 0.01% 812
2019
Q1 		$683K Sell
11,915
-29,830
-71% -$1.48M 0.03% 602
2018
Q4 		$1.75M Sell
41,745
-18,505
-31% -$1.09M 0.07% 362
2018
Q3 		$4.55M Buy
60,250
+15,724
+35% +$1.13M 0.13% 202
2018
Q2 		$3.19M Buy
+44,526
New +$2.13M 0.1% 292

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return